214 related articles for article (PubMed ID: 9865430)
1. Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection.
Sleckman BG; Mauch PM; Ambinder RF; Mann R; Pinkus GS; Kadin ME; Sherburne B; Perez-Atayde A; Thior I; Mueller N
Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1117-21. PubMed ID: 9865430
[TBL] [Abstract][Full Text] [Related]
2. Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma.
Hjalgrim H; Smedby KE; Rostgaard K; Molin D; Hamilton-Dutoit S; Chang ET; Ralfkiaer E; Sundström C; Adami HO; Glimelius B; Melbye M
Cancer Res; 2007 Mar; 67(5):2382-8. PubMed ID: 17332371
[TBL] [Abstract][Full Text] [Related]
3. Association of Epstein-Barr virus latent membrane protein and Hodgkin's disease in Mexico.
Quintanilla-Martínez L; Gamboa-Domńquez A; Gamez-Ledesma I; Angeles-Angeles A; Mohar A
Mod Pathol; 1995 Aug; 8(6):675-9. PubMed ID: 8532705
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of Hodgkin's lymphoma after infectious mononucleosis.
Hjalgrim H; Askling J; Rostgaard K; Hamilton-Dutoit S; Frisch M; Zhang JS; Madsen M; Rosdahl N; Konradsen HB; Storm HH; Melbye M
N Engl J Med; 2003 Oct; 349(14):1324-32. PubMed ID: 14523140
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus and HLA-DPB1-*0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr Virus in cases that are EBV(+ve).
Alexander FE; Jarrett RF; Cartwright RA; Armstrong AA; Gokhale DA; Kane E; Gray D; Lawrence DJ; Taylor GM
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):705-9. PubMed ID: 11401923
[TBL] [Abstract][Full Text] [Related]
6. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
7. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease.
Delsol G; Brousset P; Chittal S; Rigal-Huguet F
Am J Pathol; 1992 Feb; 140(2):247-53. PubMed ID: 1310829
[TBL] [Abstract][Full Text] [Related]
8. Childhood Hodgkin's disease in the United States: an analysis of histologic subtypes and association with Epstein-Barr virus.
Andriko JA; Aguilera NS; Nandedkar MA; Abbondanzo SL
Mod Pathol; 1997 Apr; 10(4):366-71. PubMed ID: 9110300
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus expression in Hodgkin's disease in Jordan.
Almasri NM; Khalidi HS
Saudi Med J; 2004 Jun; 25(6):770-5. PubMed ID: 15195209
[TBL] [Abstract][Full Text] [Related]
10. Expression of bcl-2 protein and Epstein-Barr virus latent membrane protein in Hodgkin's disease.
Kordek R; Biernat W; Kupnicka D; Woźniak L
Pol J Pathol; 1994; 45(4):279-81. PubMed ID: 7697330
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
[TBL] [Abstract][Full Text] [Related]
12. [Association of Epstein-Barr virus and Hodgkin's disease: comparison between Algerian and French patients].
Belkaid MI; Zerhouni F; Beljord K; Brière J; Assouak W; Djebbara Z; Andrieu JM; Colonna P
Bull Cancer; 1995; 82(5):357-63. PubMed ID: 7626843
[TBL] [Abstract][Full Text] [Related]
13. Expression of the Epstein-Barr virus encoded latent membrane protein in tumor cells of Hodgkin's disease occurring in childhood.
Kanavaros P; Sakalidou A; Gaulard P; Jiwa M; Delides G; Tzardi M; Kalmantis T; Lydaki E; Kazlaris E; Kalmanti M
Acta Morphol Hung; 1992; 40(1-4):223-30. PubMed ID: 1365766
[TBL] [Abstract][Full Text] [Related]
14. Study of association of Epstein Barr-virus with Hodgkin's disease.
Radha K; Shanthi P; Madhavan M; Senthamarai A
Indian J Pathol Microbiol; 1997 Jul; 40(3):351-4. PubMed ID: 9354006
[TBL] [Abstract][Full Text] [Related]
15. [High prevalence of the Epstein-Barr virus in a Mexican population with Hodgkin's disease].
Quintanilla-Martínez L; Gamboa-Domínguez A; Gámez-Ledesma I; Orozco-Estévez H; Angeles-Angeles A
Rev Invest Clin; 1994; 46(5):355-62. PubMed ID: 7839015
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus in Hodgkin's disease patients in Japan.
Tomita Y; Ohsawa M; Kanno H; Hashimoto M; Ohnishi A; Nakanishi H; Aozasa K
Cancer; 1996 Jan; 77(1):186-92. PubMed ID: 8630928
[TBL] [Abstract][Full Text] [Related]
17. Frequent expression of Epstein-Barr virus latent membrane protein-1 in tumour cells of Hodgkin's disease in HIV-positive patients.
Audouin J; Diebold J; Pallesen G
J Pathol; 1992 Aug; 167(4):381-4. PubMed ID: 1328576
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus infection and bcl-2 proto-oncogene expression. Separate events in the pathogenesis of Hodgkin's disease?
Khan G; Gupta RK; Coates PJ; Slavin G
Am J Pathol; 1993 Nov; 143(5):1270-4. PubMed ID: 8238244
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma.
Chang ET; Zheng T; Lennette ET; Weir EG; Borowitz M; Mann RB; Spiegelman D; Mueller NE
J Infect Dis; 2004 Jun; 189(12):2271-81. PubMed ID: 15181575
[TBL] [Abstract][Full Text] [Related]
20. Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma.
Claviez A; Tiemann M; Lüders H; Krams M; Parwaresch R; Schellong G; Dörffel W
J Clin Oncol; 2005 Jun; 23(18):4048-56. PubMed ID: 15961758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
